Screener
Neuropace, Inc. NPCE Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.
The source filing: Neuropace, Inc.’s 10-K, filed March 2, 2023.
- Filed
- Mar 2, 2023
- Fiscal year
- FY2022
- Accession
- 0001528287-23-000007
| (in thousands) | Year Ended December 31, 2022 | Year Ended December 31, 2021 |
|---|---|---|
| Taxes withheld and paid related to net share settlement of equity awards | (59) | — |
| Proceeds from issuance of common stock in initial public offering, net of underwriter discount and commissions | — | 109,089 |
| Payment of deferred offering costs | (347) | (3,392) |
| Repayment of debt | — | (4,090) |
| Net cash provided by financing activities | 490 | 102,526 |
| Net decrease in cash and cash equivalents | (12,582) | (7,447) |
| Cash, cash equivalents and restricted cash | ||
| Beginning of year | 19,309 | 26,756 |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Neuropace, Inc.'s debt repayments?
- Neuropace, Inc. (NPCE) reported debt repayments of $0 in Q4 2022.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.
Ask your AI about Neuropace, Inc.'s debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude